Natural products as inhibitors of DNA related enzymes

Current Enzyme Inhibition

Volumn 4, Issue 4, 2008, Pages 194-215

  Pungitore, Carlos R ^a  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

DNA polymerases; Inhibitors; Natural products; Reverse transcriptase; Topoisomerases

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE; ANTHRACYCLINE DERIVATIVE; BAICALIN; CAMPTOTHECIN DERIVATIVE; CATALPOL; CHROMONE DERIVATIVE; COUMARIN DERIVATIVE; DNA; DNA POLYMERASE; DNA TOPOISOMERASE; DOXORUBICIN; ENZYME INHIBITOR; FLAVONOID; IRIDOID; IRINOTECAN; LIPID; MASLINIC ACID; NATURAL PRODUCT; OLEIC ACID; PHYTOSTEROL; PROTOBERBERINE DERIVATIVE; PYRROLE DERIVATIVE; QUINONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SITOSTEROL; STIGMASTEROL; TANNIN DERIVATIVE; TRITERPENE DERIVATIVE; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME SEGREGATION; DNA METABOLISM; DNA RECOMBINATION; DNA REPLICATION; DNA TRANSCRIPTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NONHUMAN; OVARY CARCINOMA; REVIEW;

EID: 65649095577     PISSN: 15734080     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340808786733604     Document Type: Review

References (91)

1. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 2003, 66, 1022-1037.
2. Ortiz de Urbina, A.V.; Martíon, M.L.; Fernández, B.; San Román, L.; Cubillo, L. In vitro antispasmodic activity of peracetylated penstemonoside, aucubin and catalpol. Planta Med., 1994, 60, 512-515.
3. Mizushina, Y.; Iida, A.; Ohta, K.; Sugawara, F.; Sakaguchi, K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem. J., 2000, 350, 757-763.
4. Konoshima, T.; Takasaki, M.; Tokuda, H.; Nishino, H. Cancer chemopreventative activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens. Cancer Lett., 2000, 157, 87-92.
5. Hamdi, H.; Castellon, R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun., 2005, 334, 769-778.
6. Kirschberg, T.A.; Balakrishnan, M.; Huang, W.; Hluhanich, R.; Kutty, N.; Liclican, A.C.; McColl, D.J.; Squires, N.H.; Lansdon, E.B. Small molecule agonists and antagonists of F-box protein-substrate interactions in auxin perception and signaling. Bioorg. Med. Chem. Lett., 2008, 18, 1131-1134.
7. Kornberg, A.; Baker, T.A.; DNA Replication, 2nd ed.; W.H. Freeman: New York, 1991.
8. Delarue, M.; Poch, O.; Tordo, N.; Moras, D.; Argos, P. An attempt to unify the structure of polymerase. Protein Eng., 1990, 3, 461-467.
9. Li, Y.; Korolev, S.; Waksman, G. Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: Structural basis for nucleotide incorporation. EMBO J., 1998, 17, 7514-7525.
10. Protein Data Bank, access code: 4KTQ.
11. Ollis, D.L.; Brick, P.; Hamlin, R.; Xuong, N.G.; Steitz, T.A. Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. Nature, 1985, 313, 762-766.
12. Steitz, T.A. DNA- and RNA-dependent DNA polymerases. Curr. Opin. Struct. Biol., 1993, 3, 31-38.
13. Johnson, K.A. Conformational coupling in DNA polymerase fidelity. Annu. Rev. Biochem., 1993, 62, 685-713.
14. Protein Data Bank, access code: 1TV9.
15. Prasad, R.J. Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase β as revealed by site-directed mutagenesis. Biol. Chem., 1998, 273, 11121-11126.
16. Matsumoto, Y.; Kim, K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science, 1995, 269, 699-702.
17. Idriss, H.T.; Al-Assar, O.; Wilson, S.H. Molecules in focus DNA polymerase β. Int. J. Biochem. Cell. Biol., 2002, 34, 321-324.
18. Sun, D-A.; Starck, S.R.; Locke, E.P.; Hecht, S.M. DNA polymerse β inhibitors from Sandoricum koetjape. J. Nat. Prod., 1999, 62, 1110-1113.
19. Deng, J.-Z.; Starck, S.R.; Sun, D.-A.; Sabat, M.; Hecht, S.M. A new 7, 8-euphadien-type triterpenoid from Brackenridgea nitida and Bleasdalea bleasdalei that inhibits DNA polymerase β. J. Nat. Prod., 2000, 63, 1356-1360.
20. Tanaka, N.; Kitamura, A.; Mizushina, Y.; Sugawara, F.; Sakaguchi, K. Fomitellic Acids, Triterpenoid inhibitors of eukaryotic DNA polymerases from a basidiomycete, Fomitella fraxinea. J. Nat. Prod., 1998, 61, 193-197.
21. Deng, J.-Z.; Starck, S.R.; Hecht, S.M. DNA polymerase β inhibitors from Baeckea gunniana. J. Nat. Prod., 1999, 62, 1624-1626.
22. Mizushina, Y.; Ikuta, A.; Endoh, K.; Oshige, M.; Kasai, N.; Kamiya, K.; Satake, T.; Takazawa, H.; Morita, H.; Tomiyasu, H.; Yoshida, H.; Sugawara, F.; Sakaguchi, K. Inhibition of DNA polymerases and DNA topoisomerases II by triterpenes produced by plant callus. Biochem. Biophys. Res. Commun., 2003, 305, 365-373.
23. Sun, N.J.; Woo, S.H.; Cassady, J.M.; Snapka R.M. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod., 1998, 61, 362-366.
24. Deng, J-Z.; Starck, S.R.; Hecht, S.M. Bis-5-alkylresorcinols from Panopsis rubescens that inhibit DNA polymerase β. J. Nat. Prod., 1999, 62, 477-480.
25. Chen, J.; Zhang, Y.-H.; Wang, L.-K.; Sucheck, S.J.; Snow, A.M.; Hecht, S.M. Inhibitors of DNA polymerase β from Schoepfia californica. Chem. Commun., 1998, 2769-2770.
26. Mizushina, Y.; Ishidoh, T.; Kamisuki, S.; Nakazawa, S.; Takemura, M.; Sugawara, F.; Yoshida, H.; Sakaguchi, K. Flavonoid glycoside: A new inhibitor of eukaryotic DNA polymerase α and a new carrier for inhibitor-affinity chromatography. Biochem. Biophys. Res. Commum., 2003, 301, 480-487.
27. Kamisuki, S.; Ishimaru, C.; Onoda, K.; Kuriyama, I.; Ida, N.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Nodulisporol and nodulisporone, novel specific inhibitors of human DNA polymerase λ from a fungus, Nodulisporium sp. Bioorg. Med. Chem., 2007, 15, 3109-3114.
28. Mizushina, Y.; Murakami, C.; Ohta, K.; Takikawa, H.; Mori, K.; Yoshida, H.; Sugawara, F.; Sakaguchi, K. Selective inhibition of the activities of both eukaryotic DNA polymerases and DNA polymerases by elenic acid. Biochem. Pharmacol., 2002, 63, 399-407.
29. Murakami, C.; Kumagai, T.; Hada, T.; Kanekazu, U.; Nakazawa, S.; Kamisuki, S.; Maeda, N.; Xu, X.; Yoshida, H.; Sugawara, F.; Sakaguchi, K.; Mizushina, Y. Effects of glycolipids from spinach on mammalian DNA polymerases. Biochem. Pharmacol., 2003, 65, 259-267.
30. Kobayashi, J.; Mikami, S.; Shigemori, H.; Takao, T.; Shimonishi, Y.; Izuta, S.; Yoshida, S. Flavocristamides A and B, new DNA polymerases α inhibitors from a marine bacterium Flavobacterium sp. Tetrahedron, 1995, 51, 10487-10490.
31. Pungitore, C.R.; Juri Ayub, M.; García, M.; Borkowski, E.J.; Sosa, M.E.; Ciuffo, G.; Giordano, O.S.; Tonn, C.E. Iridoids as allelochemicals and DNA polymerase inhibitors. J. Nat. Prod., 2004, 67, 357-361.
32. Pungitore, C.R.; Juri Ayub, M.; Borkowski, E.J.; Tonn, C.E.; Ciuffo, G.M. Inhibition of Taq DNA polymerase by catalpol. Cell. Mol. Biol., 2004, 50, 767-772.
33. Pungitore, C.R.; León, L.G.; García, C.; Martín, V.S.; Tonn, C.E.; Padrón, J.M. Novel antiproliferative analogs of the Taq DNA polymerase inhibitor catalpol. Bioorg. Med. Chem. Lett., 2007, 17, 1332-1335.
34. Mizushina, Y.; Nakanishi, R.; Kuriyama, I.; Kamiya, K.; Satake, T.; Shimazaki, N.; Koiwai, O.; Uchiyama, Y.; Yonezawa, Y.; Takemura, M.; Sakaguchi, K.; Yoshida, H. β-Sitosterol-3-O-β-D-glucopyranoside: A eukaryotic DNA polymerase λ inhibitor. J. Steroid Biochem. Mol. Biol., 2006, 99, 100-107.
35. Li, S.-S.; Gao, Z.; Feng, X.; Jones, S.H.; Hecht, S.M. Plant sterols as selective DNA polymerase β lyase inhibitors and potentiators of bleomycin cytotoxicity. Bioorg. Med. Chem., 2004, 12, 4253-4258.
36. Mizushina, Y.; Saito, A.; Tanaka, A.; Nakajima, N.; Kuriyama, I.; Takemura, M.; Takeuchi, T.; Sugawara, F.; Yoshida, H. Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors. Biochem. Biophys. Res. Commun., 2005, 333, 101-109.
37. Naganuma, M.; Nishida, M.; Kuramochi, K.; Sugawara, F.; Yoshida, H.; Mizushina, Y. 1-Deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Bioorg. Med. Chem., 2008, 16, 2939-2944.
38. Nishida, M.; Hada, T.; Kuramochi, K.; Yoshida, H.; Yonezawa, Y.; Kuriyama, I.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Diallyl sulfides: selective inhibitors of family X DNA polymerases from garlic (Allium sativum L.). Food Chem., 2008, 108, 551-560.
39. Mizushina, Y.; Yagita, E.; Kuramochi, K.; Kuriyama, I.; Shimazaki, N.; Koiwai, O.; Uchiyama, Y.; Yomezawa, Y.; Sugawara, F.; Kobayashi, S.; Sakaguchi, K.; Yoshida, H. 5-(Hidroxymethyl)-2-furfural: A selective inhibitor of DNA polymerase λ and terminal deoxynucleotidyltransferase. Arch. Biochem. Biophys., 2006, 446, 69-76.
40. Oshige, M.; Takenouchi, M.; Kato, Y.; Kamisuki, S.; Takeuchi, T.; Kuramochi, K.; Shiina, I.; Suenaga, Y.; Kawakita, Y.; Kuroda, K.; Sato, N.; Kobayashi, S.; Sugawara, F.; Sakaguchi, K. Taxol derivatives are selective inhibitors of DNA polymerase α. Bioorg. Med. Chem., 2004, 12, 2597-2601.
41. Kimura, T.; Nishida, M.; Kuramochi, K.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Novel azaphilones, kasanosins A and B, which are specific inhibitors of eukaryotic DNA polymerases β and λ from Talaromyces sp. Bioorg. Med. Chem., 2008, 16, 4594-4599.
42. Nishida, M.; Ida, N.; Horio, M.; Takeuchi, T.; Kamisuki, S.; Murata, H.; Kuramochi, K.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Hymenoic acid, a novel specific inhibitor of human DNA polymerase λ from a fungus of Hymenochaetaceae sp. Bioorg. Med. Chem., 2008, In press.
43. Maeda, N.; Kokai, Y.; Ohtani, S.; Sahara, H.; Kuriyama, I.; Kamisuki, S.; Takahashi, S.; Sakaguchi, K.; Sugawara, F.; Yoshida, H.; Sato, N.; Mizushina, Y. Anti-tumor effects of dehydroaltenusin, a specific inhibitor of mammalian DNA polymerase α. Biochem. Biophys. Res. Commun., 2007, 352, 390-396.
44. Mizushina, Y.; Ueno, T.; Oda, M.; Yamaguchi, T.; Saneyoshi, M.; Sakaguchi, K. The biochemical mode of inhibition of DNA polymerase β by α-rubromycin. Biochim. Biophys. Acta, 2000, 1523, 172-181.
45. Deng, J.-Z.; Starck, S.R.; Hecht, S.M.; Ijames, C.F.; Hemling, M.E. Harbanic acid, a novel and potent DNA polymerase β inhibitor from Hardwickia binata. J. Nat. Prod., 1999, 62, 1000-1002.
46. Mizushina, Y.; Nakagawa, K.; Shibata, A.; Awata, Y.; Kuriyama, I.; Shimazaki, N.; Koiwai, O.; Uchiyama, Y.; Sakaguchi, K.; Miyazawa, T.; Yoshida, H. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase λ and angiogenesis. Biochem. Biophys. Res. Commun., 2006, 339, 949-955.
47. Ismail, I.; Ito, H.; Hatano, T.; Taniguchi, S.; Yoshida, T. Modified limonoids from the leaves of Sandoricum koetjape. Phytochemistry, 2003, 641, 345-1349.
48. Yaoita, Y.; Kikuchi, M. Seco-eremophilane derivatives from rhizomes of Petasites Japonicus. Phytochemistry, 1996, 42, 751-755.
49. Shri, R.; Singh, K. Neuroprotective effect of methanolic extracts of Allium cepa on ischemia and reperfusion-induced cerebral injury. Fitoterapia, 2008, 79, 86-96.
50. Jaziri, I.; Ben Slama, M.; Mhadhbi, H.; Urdaci, M.; Hamdi, M. Effect of green and black teas (Camellia sinensis L.) on the characteristic microflora of yogurt during fermentation and refrigerated storage. Food Chem., 2009, 112, 614-620.
51. Gellert, M.; Mizuchi, K.; O'Dea, M.H.; Nash, H.A. Preparations containing DNA gyrase activity has been extensively purified from Escherichia coli. Proc. Natl. Acad. Sci. USA, 1976, 73, 3872-3876.
52. Miller, K.G.; Liu, L.F.; Englund, P.T. A homogeneous type II DNA topoisomerase from HeLa cell nuclei. J. Biol. Chem., 1981, 256, 9334-9339.
53. Protein Data Bank, access code: 1EJ9.
54. Yang, Z.; Champoux, J.J. The role of Histidine 632 in catalysis by human topoisomerase I. J. Biol. Chem., 2001, 276, 677-685.
55. Redinbo, M.R.; Stewart, L.; Kuhn, P.; Champoux, J.J.; Hol, W.G.J. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science, 1998, 279, 1504-1513.
56. Redinbo, M.R.; Champoux, J.J.; Hol, W.G.J. Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry, 2000, 39, 6832-6840.
57. Bailly, C. Homocamptothecins: Potent topoisomerase I inhibitors and promising anticancer drugs. Crit. Rev. Oncol. Hematol., 2003, 45, 91-108.
58. Baguley, B.C. In Anticancer drug Development; Elsevier Inc.: USA, 2002; Chap. 1, pp. 1-11.
59. Kerrigan, J.E.; Pilch, D.S. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin. Biochemistry, 2001, 40, 9792-9798.
60. Laco, G.S.; Collins, J.R.; Luke, B.T.; Kroth, H.; Sayer, J.M.; Jerina, D.M.; Pommier, Y. Human topoisomerase I inhibition: Docking camptothecin and derivatives into a structure-based active site model. Biochemistry, 2002, 41, 1428-1435.
61. Bailly, C. Irinotecan (CPT-11): Pharmacology and clinical applications. Crit. Rev. Oncol. Hematol., 1996, 24, 3-26.
62. Larsen, A.K.; Escargueil, A.E.; Skladanowski, A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol. Ther., 2003, 99, 167-181.
63. Sim, S.-P.; Gatto, B.; Yu, C.; Liu, A.A.; Li, T.-K.; Pilch, D.S.; LaVoie, E.J.; Liu, L.F. Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar. Biochemistry, 1997, 36, 13285-13291.
64. Tan, C.; Tasaka, H.; Kou-Ping, Y. Daunomycin, an antitumor antibiotic in the treatment of neoplastic disease. Cancer, 1967, 20, 333-353.
65. Ting, C.Y; Hsu, C.; Hsu, H.T.; Su, J.S.; Chen, J.Y.; Tarn, W.Y; Kuo, Y.H.; Whang-Peng, J.; Liu, L.F.; Hwang, J. Isodiospyrin as a novel human DNA topoisomerase I inhibitor. J. Biochem. Pharmacol., 2003, 66, 1981-1991.
66. Meng, L.; Zhang, J.; Ding, J. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem. Pharmacol., 2001, 62, 733-741.
67. Pungitore, C.R.; Padrón, J.M.; León, L.G.; García, C.; Ciuffo, G.M.; Martín, V.S.; Tonn, C.E. Inhibition of DNA topoisomerase I and growth inhibition of human cancer cell lines by an oleanane from Junellia aspera (Verbenaceae) Cell. Mol. Biol., 2007, 53, 13-17.
68. Wada, S.; Iida, A.; Tanaka, R. Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. J. Nat. Prod., 2001, 64, 1545-1547.
69. Montaner, B.; Castillo-Ávila, W.; Martinell, M.; Ollinger, R.; Aymani, J.; Giralt, E.; Pérez-Tomás, R. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin. Toxicol. Sci., 2005, 85, 870-879.
70. Prudhomme, M. Rebeccamycin analogues as anti-cancer agents. Eur. J. Med. Chem., 2003, 38, 123-140.
71. Li, T.; Bathory, E.; LaVoie, E.J.; Srinivasan, A.R.; Olson, W.K.; Sauers, R.R.; Liu, L.F.; Pilch, D.S. Human topoisomerase I poisoning by protoberberines: Potential roles for both drug-DNA and drug-enzyme interactions. Biochemistry, 2000, 39, 7107-7116.
72. Makhey, D.; Li, D.; Zhao, B.; Sim, S.-P.; Li, T.-K.; Liu, A.; Liub, L.F.; LaVoiea, E.J. Substituted benzo [i]phenanthridines as mammalian topoisomerase-targeting agents. Bioorg. Med. Chem., 2003, 11, 1809-1820.
73. Bertounesque, E.; Meresse, P.; Monneret, C.; Florent J.-C. Synthetic approach to condensed heterocyclic analogues from etoposide revisited. Synthesis of A-ring pyridazine etoposide. Tetrahedron Lett., 2007, 48, 5781-5784.
74. Liu, Y.-Q.; Yang, L.; Tian, X. Podophyllotoxin: Current perspectives. Curr. Bioact. Comp., 2007, 3, 37-66.
75. Jensen, L.H.; Renodon-Corniere, A.; Nitiss, K.C.; Hill, B.T.; Nitiss, J.L.; Jensen, P.B.; Sehested, M. A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II α. Biochem. Pharmacol., 2003, 66, 623-631.
76. Suzuki, K.; Okawara, T.; Higashijima, T.; Yokomizo, K.; Mizushima, T.; Otsuka, M. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships. Bioorg. Med. Chem. Lett., 2005, 15, 2065-2068.
77. Umemura, K.; Yanase, K.; Suzuki, M.; Okutani, K.; Yamori, T.; Andoh, T. Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharide. Biochem. Pharmacol., 2003, 66, 481-487.
78. Walsh, A.H.; Cheng, A.; Honkanen, R.E. Rebeccamycin analogues as anti-cancer agents. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett., 1997, 416, 230-234.
79. Xu, J.; Chang, J.; Zhao, M.; Zhang, J.-S. Abietane diterpenoid dimers from the roots of Salvia prionitis. Phytochemistry, 2006, 67, 795-799.
80. Protein Data Bank, access code: 1S1X.
81. Arnold, E.; Ding, J.; Hughes, S.H.; Hostomsky, Z. Structures of DNA and RNA polymerases and their interactions with nucleic acid substrates. Curr. Opin. Struct. Biol., 1995, 5, 27-38.
82. Debyser, Z.; Pauwels, R.; Andries, K.; De Clercq, E. Specific HIV-1 reverse transcriptase inhibitors. J. Enzyme Inhib., 1992, 6, 47-53.
83. Mitsuya, H.; Development of inhibitors of reverse transcriptase and protease as therapeutics against HIV infection. J. Enzyme Inhib., 1992, 6, l-8.
84. Yarchoan, R.; Broker, S. Correlations between the in vitro and in vivo activity of anti-HIV agents: Implications for future drug development. J. Enzyme Inhib., 1992, 6, 99-111.
85. Ng, T.B.; Huang, B.; Fong, W.P.; Yeung, H.W. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors. Life Sci., 1997, 61, 933-949.
86. Loya, S.; Reshef, V.; Mizrachi, E.; Silberstein, C.; Rachamim, Y.; Carmeli, S.; Hizi, A. The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: Contribution of different moieties to their high potency. J. Nat. Prod., 1998, 61, 891-895.
87. Sheeja, K.; Guruvayoorappan, C.; Kuttan, G. Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int. Immunopharmacol., 2007, 7, 211-221.
88. Ito, H.; Miyake, M.; Nishitani, E.; Mori, K.; Hatano, T.; Okuda, T.; Konoshima, T.; Takasaki, M.; Kozuka, M.; Mukainaka, T.; Tokuda, H.; Nishino, H.; Yoshida, T. Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima. Cancer Lett., 1999, 143, 5-13.
89. Tona, L.; Kambu, K.; Ngimbi, N.; Cimanga, K.; Vlietinck, A.J. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J. Ethnopharmacol., 1998, 61, 57-65.
90. Laure, F.; Raharivelomanana, P.; Butaud, J.-F.; Bianchini, J.-P.; Gaydou, E. Screening of anti-HIV-1 inophyllums by HPLC-DAD of Calophyllum inophyllum leaf extracts from French Polynesia Islands. Anal. Chim. Acta, 2008, 624, 147-153.
91. Yang, H.; Duan, Y.; Hu, F.; Liu, J. Lack of altitudinal trends in phytochemical constituents of Swertia franchetiana (Gentianaceae). Biochem. Syst. Ecol., 2004, 32, 861-866.